tiprankstipranks
Mind Medicine (MNMD)
NASDAQ:MNMD
Holding MNMD?
Track your performance easily

Mind Medicine (MNMD) Ownership - Who Owns Mind Medicine?

1,437 Followers

Mind Medicine (MNMD) Ownership Overview

2.52%5.28%42.51%8.19%41.50%
42.51% Other Institutional Investors
8.19% ETFs
41.50% Public Companies and Individual Investors
The ownership structure of Mind Medicine (MNMD) stock is a mix of institutional, retail, and individual investors. Approximately 55.98% of the company’s stock is owned by Institutional Investors, 2.52% is owned by Insiders, and 41.50% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 26, 2024
David Gryska
Director
xxxxxxxxxxxxx
$20930
Aug 20, 2024
Robert Barrow
Ceo,director
xxxxxxxxxxxxx
$6215
Mar 26, 2024
Schond L Greenway
Chief Financial Officer
xxxxxxxxxxxxx
$54377
Mar 26, 2024
Daniel Rollings Karlin
Chief Medical Officer
xxxxxxxxxxxxx
$62491

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
3,912,479Institution5.34%29,578,341
3,894,127Institution5.31%29,439,600
3,135,956Institution4.28%23,707,827
1,738,603Institution2.37%13,143,839
1,025,154Institution1.40%7,750,164
1,002,544Institution1.37%7,579,233
767,146Institution1.05%5,799,624
685,600Institution0.93%5,183,136
545,772Insider0.74%4,126,036
395,391Institution0.54%2,989,156

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,025,154Institution1.40%7,750,164
767,146Institution1.05%5,799,624
685,600Institution0.93%5,183,136
367,396Institution0.50%2,777,514
240,415Institution0.33%1,817,537
208,310Institution0.28%1,574,824
203,810Institution0.28%1,540,804
159,960Institution0.22%1,209,298
77,522Institution0.11%586,066
33,354Institution0.05%252,156

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,986,991Institution2.71%15,021,652
1,046,445Institution1.43%6,592,604
646,073Institution0.88%4,884,312
350,943Institution0.48%2,488,186
327,918Institution0.45%2,065,883
241,027Institution0.33%1,708,881
178,699Institution0.24%1,350,964
202,681Institution0.28%1,276,890
164,643Institution0.22%1,244,701
101,893Institution0.14%770,311

FAQ

Who Owns Mind Medicine (MNMD)?
According to the latest TipRanks data, approximately 42.51% of the company's stock is held by institutional investors, 2.52% is held by insiders, and 41.50% is held by retail investors.
    What percentage of Mind Medicine (MNMD) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 42.51% of Mind Medicine (MNMD) stock is held by institutional investors.
      What percentage of Mind Medicine (MNMD) stock is held by retail investors?
      According to the latest TipRanks data, approximately 41.50% of Mind Medicine (MNMD) stock is held by retail investors.
        Who owns the most shares of Mind Medicine (MNMD)?
        Stephen A. Schwarzman owns the most shares of Mind Medicine (MNMD).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis